Investment Counsel Company of Nevada’s Globus Medical GMED Stock Holding History

Investment Counsel Company of Nevada’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79K	Hold	1,000	–	–	0.15%	44
2026 Q1	$86.2K	Hold	1,000	–	–	0.19%	37
2025 Q4	$87.3K	Hold	1,000	–	–	0.19%	37
2025 Q3	$57.3K	Hold	1,000	–	–	0.12%	43
2025 Q2	$59K	Hold	1,000	–	–	0.12%	48
2025 Q1	$73.2K	Hold	1,000	–	–	0.17%	41
2024 Q4	$82.7K	Buy	+1,000	New	+$78.9K	0.21%	27

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Investment Counsel Company of Nevada's GMED Position: Q2 2026 in Review

Investment Counsel Company of Nevada held its Globus Medical (GMED) position steady in Q2 2026 at 1,000 shares worth $79K. The position accounts for 0.15% of the portfolio, ranked #44.

Investment Counsel Company of Nevada first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. The position peaked at $87.3K in Q4 2025. 414 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Investment Counsel Company of Nevada held 1,000 shares of Globus Medical worth $79K as of Q2 2026.
Investment Counsel Company of Nevada left its Globus Medical share count unchanged in Q2 2026.
Globus Medical made up 0.15% of Investment Counsel Company of Nevada's portfolio in Q2 2026, its #44 holding.
Investment Counsel Company of Nevada first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
Investment Counsel Company of Nevada's Globus Medical position peaked at $87.3K in Q4 2025.
414 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Investment Counsel Company of Nevada's 13F filing for Q2 2026, filed 10 Aug 2026.